Home / Individualized immune-related gene signature predicts immune status and oncologic outcomes in clear cell renal call carcinoma patients
Publication: March 2019
Predictive biomarkers remain an unmet medical need in RCC.
Several investigations were presented in this interesting session to assess the meaning of genomic profil in RCC patients.
We are moving on how to translate molecular features of the disease into a personalized approach for kidney cancer patients.